Copernicus revisited: Amyloid beta in Alzheimer's disease

Neurobiology of Aging

Volumn 22, Issue 1, 2001, Pages 131-146

  Josepha, James ^a   Shukitt Hale, Barbara ^a   Denisova, Natalia A ^a   Martin, Antonio ^a   Perry, George ^b   Smith, Mark A ^b  

^a TUFTS UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN; CYTOKINE; MEMBRANE LIPID;

AGING; ALZHEIMER DISEASE; BEHAVIOR; CELL LOSS; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; INFLAMMATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

EID: 0035054836     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(00)00211-6     Document Type: Note

References (189)

1. Inflammation and Alzheimer's disease: Mechanisms and therapeutic strategies
2. Reactive synaptogenesis in hippocampal area CA1 of aged and young adult rats
3. Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease
4. Role of sphingolipid-mediated cell death in neurodegenerative diseases
5. GM1 inhibits amyloid beta-protein-induced cytokine release
6. Surface composition regulates clearance from plasma and triolein lipolysis of lipid emulsions
7. Commodity consumption and ischemic heart disease mortality, with special reference to dietary practices
8. Lipid binding to amyloid beta-peptide aggregates: Preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids
9. Ganglioside composition and content of rat-brain subcellular fractions
10. Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study
11. Impairments in learning and memory accompanied by neurodegeneration in mice transgenic for the carboxyl-terminus of the amyloid precursor protein
12. Deterioration threshold of synaptic morphology in aging and senile dementia of Alzheimer's type
13. Elimination of β-amyloid neurotoxicity
14. Inherited neurodegenerative diseases and transgenic models
15. Transformation of arachidonic acid and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes
16. Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase
17. Hippocampal neuron and synaptophysin-positive bouton number in aging C57BL/6 mice
18. Apolipoprotein E epsilon4 is associated with neuronal loss in the substantia nigra in Alzheimer's disease
19. Antioxidant capacity of tea and common vegetables
20. Aging- and oxygen-induced modifications in brain biochemistry and behavior
21. The relationship of aging to endotoxin shock and to production of TNF-α
22. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
23. The neurochemical and behavioral effects of beta-amyloid peptide (25-35)
24. Lipid peroxidation contributes to age-related membrane rigidity
25. Brain synaptosomal aging: Free radicals and membrane fluidity
26. Oxidative stress and Alzheimer's disease
27. Beta-amyloid(1-40) effects on behavior and memory
28. Mechanisms of neuronal death in Alzheimer's disease
29. M GTPase activity in aging and Alzheimer's disease: Implications for impaired signal transduction
30. α-linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex
31. Microvascular responses to cerebral ischemia/inflammation
32. Differential effect of aging on cholesterol modulation of carbachol stimulated Low-Km GTPase in striatal synaptosomes
33. The role of glutathione, membrane sphingomyelin, and its metabolites in oxidative stress-induced calcium "dysregulation" in PC12 cells
34. Oxidant injury in PC-12 cells: A possible model of calcium "dysregulation" in aging II: Interactions with membrane lipids
35. Spatial learning deficit in mice expressing human 751-amino acid β-amyloid precursor protein
36. Role of translocases in the generation of phosphatidylserine asymmetry
37. Microgila cell activation and Alzheimer disease: Partial linkage with neurofibrillary tangle burden in the hippocampus
38. An overview of the epidemiological evidence linking diet and cancer
39. Bilateral injections of beta A(25-35) + IBO into the hippocampus disrupts acquisition of spatial learning in the rat
40. Functional acetylcholine muscarinic receptor subtypes in human brain microcirculation: Identification and cellular localization
41. Membrane phospholipid alterations in Alzheimer's disease: Deficiency of ethanolamine plasmalogens
42. The neurobiology and pharmacotherapy Alzheimer's disease
43. Amnestic effects in mice of four synthetic peptides homologous to amyloid beta protein from patients with Alzheimer disease
44. An amyloid beta-protein fragment, A beta[12-28], equipotently impairs post-training memory processing when injected into different limbic system structures
45. Production of prostaglandin E and interleukin-1 like factor by cultured astrocytes and C-6 glioma cells
46. Alzheimer's, ageing and amyloid: An absurd allegory?
47. Magnetic resonance microscopy of iron in the basal forebrain cholinergic structures of the aged mouse lemur
48. Topographical localization of lipofuscin pigment in the brain of the aged fat-tailed dwarf lemur (Cheirogaleus medius) and grey lesser mouse lemur (Microcebus murinus): Comparison to iron localization
49. Differential effects of amyloid peptides beta-(1-40) and beta-(25-35) injections into the rat nucleus basalis
50. Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease
51. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species
52. Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable ceramide
53. Protective role of black tea against oxidative damage of human red blood cells
54. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons
55. The effects of a novel NSAID on chronic neuroinflammation are age dependent
56. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
57. Strain dependent and invariant features of transgenic mice expressing Alzheimer amyloid precursor protein
58. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice
59. Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma
60. Diet and coronary heart disease - A review
61. Transbilayer distribution of cholesterol is modified in brain synaptic plasma membranes of knockout mice deficient in the low-density lipoprotein receptor, apolipoprotein E, or both proteins
62. Increasing age alters transbilayer fluidity and cholesterol asymmetry in synaptic plasma membranes of mice
63. Dysfunction of cholinergic and dopaminergic neuronal systems in β-amyloid protein-infused rats
64. Cholinergic activation of phosphoinositide signaling is impaired in Alzheimer's disease brain
65. Receptor- and age-selective effects of dopamine oxidation on receptor-G protein interactions in the striatum
66. Reversals of age-related declines in neuronal signal transduction, cognitive and motor behavioral deficits with blueberry, spinach or strawberry dietary supplementation
67. Long-term dietary strawberry, spinach or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral deficits
68. Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production
69. Dissociation of striatal GTPase and dopamine release responses to muscarinic cholinergic agonists in F344 rats. Influence of age and dietary manipulation
70. Aggregation of beta-amyloid peptide is promoted by membrane phospholipid metabolites elevated in Alzheimer's disease brain
71. Protein-facilitated export of arachidonic acid from pig neutrophils
72. Altered synaptic plasticity in hippocampal CA1 area of apolipoprotein E deficient mice
73. Neurodegeneration in Alzheimer disease. Is apoptosis involved?
74. Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease
75. Two pools of cholesterol in acetylcholine receptor-rich membranes from Torpedo
76. Muscarinic acetylcholine receptor expression in memory circuits: Implications for treatment of Alzheimer disease
77. Age-associated changes in the content and fatty acid composition of brain glycerophospholipids
78. Inflammation, A beta deposition, neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration
79. Secondary mechanisms in neuronal trauma
80. Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells
81. Oxidative alterations in Alzheimer's disease
82. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease
83. Distribution and fluidizing action of soluble and aggregated amyloid beta-peptide in rat synaptic plasma membranes
84. Observations on the astrocyte response to a cerebral stab wound in adult rats
85. Interactions of amyloid beta-peptide (1-40) with ganglioside-containing membranes
86. Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: Evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration
87. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases
88. Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction
89. Beta-carotene, carotenoids and disease prevention in humans
90. Present imperfect: A critical review of animal models of the mnemonic impairments in Alzheimer's disease
91. The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases
92. Characterization of the interactions of Alzheimer beta-amyloid peptides with phospholipid membranes
93. Structural transitions associated with the interaction of Alzheimer beta-amyloid peptides with gangliosides
94. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease
95. Inflammatory events at the blood brain barrier: Regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species
96. Some cholinergic themes related to Alzheimer's disease: Synaptology of the nucleus basalis, location of m2 receptors, interactions with amyloid metabolism, and perturbations of cortical plasticity
97. Apolipoprotein E exhibits isoform-specific promotion of efflux from astrocytes and neurons in culture
98. Bcl-2 protein expression in aged brain and neurodegenerative diseases
99. Microglia as effector cells in brain damage and repair: Focus on prostanoids and nitric oxide
100. Cellular mechanisms of hypoxic injury in the developing brain
101. Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human β-amyloid precursor protein
102. Toward understanding of the molecular basis of loss of neuronal plasticity in ageing
103. Determinants of neuronal vulnerability in neurodegenerative diseases
104. Interleukin-1 induces lipid peroxidation and membrane changes in rat hippocampus: An age-related study
105. Alzheimer's disease animal models induced by continuous infusion of β-amyloid protein and anti-nerve growth factor antibody
106. Toxicity of β-amyloid protein: Neurochemical, histological and behavioral changes
107. Memory impairment and neuronal dysfunction induced by beta-amyloid protein in rats
108. The cell cycle division cycle and the pathophysiology of Alzheimer's disease
109. Age-changes of brain synapses and synaptic plasticity in response to an enriched environment
110. Alzheimer's disease: A re-examination of the amyloid hypothesis
111. Contribution of a metal-peroxide adduct to neurodegeneration is due to its oxidative protease activity
112. Continuous infusion of beta-amyloid protein into the rat cerebral ventricle induces learning impairment and neuronal and morphological degeneration
113. β-amyloid protein-induced Alzheimer's disease animal model
114. Delayed behavioral effects following intrahippocampal injection of aggregated A beta (1-42)
115. An introduction to the free radical hypothesis in Parkinson's disease
116. Alternative, no-secretase processing of Alzheimer's beta-amyloid precursor protein during apoptosis by caspase-6 and -8
117. Amyloid-β junkies
118. No hippocampal neuron or synaptic bouton loss in learning-impaired aged beta-amyloid precursor protein-null mice
119. Role of apolipoprotein E in modulating neurite outgrowth potential effect of intracellular apolipoprotein E
120. Apolipoprotein E: A pharmacogenetic target for the treatment of Alzheimer's disease
121. Mitotic phosphorylation of tau protein in neuronal cell lines resembles phosphorylation in Alzheimer's disease
122. Antioxidant capacity as influenced by total phenolic and anthocyanin content, maturity and variety of Vaccinium species
123. Expression of fatty acid binding proteins is altered in the aged mouse brain
124. Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro
125. Superoxide reacts with nitric oxide to nitrate tyrosine physiological pH via peroxynitrite
126. Inflammation and Alzheimer's disease pathogenesis
127. Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines
128. The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling
129. Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging
130. Age-related activation of microglya and astrocytes: In vivo studies show persistent phenotypes and aging, increased proliferation, and resistance to down-regulation
131. Bcl-2 family members in the development and degenerative pathologies of the nervous system
132. Decreased synaptic density in aged brains and its prevention by rearing under enriched environment as revealed by synaptophysin contents
133. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study
134. Age-related hippocampal changes in Bcl-2:Bax ratio, oxidative stress, redox-active iron and apoptosis associated with aluminum-induced neurodegeneration: Increased susceptibility with aging
135. 4 Hydroxynonenol-derived advanced lipid peroxidation end products are increased in Alzheimer's disease
136. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: A central role for bound transition metals
137. Mechanisms of neurotoxicity associated with amyloid beta deposition and the role of free radicals in the pathogenesis of Alzheimer's disease: A critical appraisal
138. Quantitative assessment of synaptic density in the outer molecular layer of the hippocampal dentate gyrus in Alzheimer's disease
139. Astrocytes, brain aging, and neurodegeneration
140. Selective oxidation and externalization of membrane phosphatidylserine: Bcl-2-induced potentiation of the final common pathway for apoptosis
141. Recent advances in membrane cholesterol domain dynamics and intracellular cholesterol trafficking
142. The localization of gangliosides in neurons of the central nervous system: The use of anti-ganglioside antibodies
143. Transgenic animals relevant to Alzheimer's disease
144. Amyloid protein and Alzheimer's disease
145. Beta-amyloid 25-35 and/or quinolinic acid injections into the basal forebrain of young male Fischer-344 rats: Behavioral, neurochemical and histological effects
146. Bilateral injections of amyloid-beta 25-35 into the amygdala of young Fischer rats: Behavioral, neurochemical, and time dependent hipathological effects
147. The protective role of plasmalogens in iron-induced lipid peroxidation
148. Transgenic mouse models of Alzheimer's disease
149. Cerebral astrocytes transport ascorbic acid and dehydroascorbic acid through distinct mechanisms regulated by cyclic AMP
150. Depletion of plasma membrane sphingomyelin rapidly alters the distribution of cholesterol between plasma membranes and intracellular cholesterol pools in cultured fibroblasts
151. Widespread peroxynitrite-mediated damage in Alzheimer's disease
152. Abnormal localization of iron regulatory protein in Alzheimer's disease
153. An important role of haparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar Ab-amyloid in rat brain
154. Lipid compositions in different regions in Alzheimer's disease/senile dementia of Alzheimer's type
155. Behavioral and neuropathologic changes induced by central injection of carboxyl-terminal fragment of β-amyloid precursor protein in mice
156. Coronary artery disease, hypertension, ApoE, and cholesterol: A link to Alzheimer's disease?
157. ICAM-1, VCAM-1, and MAdCAM-1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro
158. Interleukin-1 enhances the ATP-evoked release of arachidonic acid from mouse astrocytes
159. Lipid modulation of nicotinic acetylcholine receptor function: The role of membrane lipid composition and fluidity
160. Membrane lipids in the aging human brain
161. Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II)
162. Aging and food restriction: Effect on lipids of cerebral cortex
163. NC-1900, an active fragment analog of arginine vasopressin, improves learning and memory deficits induced by β-amyloid protein in rats
164. The prediction and prevention of Alzheimer's disease - Towards a research agenda
165. Fruit and vegetable consumption and cardiovascular mortality
166. Total antioxidant capacity of fruits
167. The bacterial endotoxin lipopolysaccharide causes rapid inappropriate excitation in rat cortex
168. Neural membrane phospholipids in Alzheimer disease
169. Neuronotrophic factors released by C6 glioma cells
170. Structure, function, and membrane integration of defensins
171. Diet and health: What should we eat?
172. Lack of long-term effects after beta-amyloid protein injections in rat brain
173. Assessing the effects of the 129/Sv genetic background on swimming navigation learning in transgenic mutants: A study using mice with a modified β-amyloid precursor protein gene
174. Cholesterol oxidation reduces Ca(2+) + MG (2+)-ATPase activity, interdigitation, and increases fluidity of brain synaptic plasma membranes
175. Recent advances in brain cholesterol dynamics: Transport, domains and Alzheimer's disease
176. Membranes and ethanol: Lipid domains and lipid-protein interactions
177. Changes in lipid composition of cortical synaptosomes from different age group of mice
178. Cytokine production in the central nervous system
179. Changes in ciliary neurotrophic factor content in the rat brain after continuous intracerebroventricular infusion of β-amyloid (1-40) protein
180. Protective effects of idebenone and alpha-tocopherol on beta-amyloid-(1-42)-induced learning and memory deficits in rats: Implications of oxidative stress in beta-amyloid-induced neurotoxicity in vivo
181. Improvement by nefiracetam of beta-amyloid-(1-42)-induced learning and memory impairments in rats
182. Decrement in muscarinic-receptor stimulated low KM GTPase in striata and hippocampus from aged rat
183. GM1 ganglioside-bound amyloid beta-protein (A beta): A possible form of preamyloid in Alzheimer's disease
184. Characterization of plasmalogen-selective phospholipase A2 from bovine brain
185. Essential fatty acids and the brain: Possible health implications
186. Cellular defenses against damage from reactive oxygen species
187. Effects of reactive oxygen species on brain synaptic plasma membrane Ca(2+)-ATPase
188. The lipid compositions of different regions of rat brain during development and aging
189. Reductions in brain phosphatidylinositol kinase activities in Alzheimer's disease